Asian Phytoceuticals PCL (BKK:APCO-R) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
Asian Phytoceuticals PCL Forward PE Ratio Related Terms
Asian Phytoceuticals PCL Forward PE Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asian Phytoceuticals PCL Forward PE Ratio Chart
Asian Phytoceuticals PCL Annual Data
Trend
Forward PE Ratio
Asian Phytoceuticals PCL Quarterly Data
Forward PE Ratio
BKK:APCO-R vs PG, CL, KVUE: Forward PE Ratio Comparison
For the Household & Personal Products subindustry, Asian Phytoceuticals PCL's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asian Phytoceuticals PCL Forward PE Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Asian Phytoceuticals PCL's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where Asian Phytoceuticals PCL's Forward PE Ratio falls into.
Asian Phytoceuticals PCL Forward PE Ratio Calculation
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
Asian Phytoceuticals PCL (BKK:APCO-R) has a Forward PE Ratio of 0.00 as of Jun. 30, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Asian Phytoceuticals PCL and its competitors. According to the industry distribution chart, Asian Phytoceuticals PCL ranks #999999 out of 744 companies in the Consumer Packaged Goods industry.
Is Asian Phytoceuticals PCL's Forward PE Ratio too high?
Asian Phytoceuticals PCL's current Forward PE Ratio is 0.00. Based on the distribution chart, Asian Phytoceuticals PCL ranks #999999 out of 744 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Asian Phytoceuticals PCL has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Asian Phytoceuticals PCL's Forward PE Ratio compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Asian Phytoceuticals PCL ranks #999999 out of 744 companies for Forward PE Ratio. This places Asian Phytoceuticals PCL in the lower half of its industry. The industry median Forward PE Ratio is 14.01. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Consumer Packaged Goods company?
The median Forward PE Ratio among Consumer Packaged Goods companies is 14.01, based on 744 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Asian Phytoceuticals PCL and its competitors. For the Consumer Packaged Goods industry, the median Forward PE Ratio is 14.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asian Phytoceuticals PCL's current Forward PE Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asian Phytoceuticals PCL stock overvalued right now?
Asian Phytoceuticals PCL (BKK:APCO-R) has a current Forward PE Ratio of 0.00. The stock's GF Value™ is ฿7.61, compared to a current price of ฿6.27 — trading 17.6% below its estimated fair value. The current Forward PE Ratio is 0.00. Asian Phytoceuticals PCL's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Asian Phytoceuticals PCL (BKK:APCO-R), the current Forward PE Ratio is 0.00 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Asian Phytoceuticals PCL (BKK:APCO-R) Overvalued in 2026?
Based on GuruFocus' analysis, Asian Phytoceuticals PCL stock appears to be undervalued.
The current stock price of ฿6.27 is trading 17.6% below its estimated GF Value™ of ฿7.61.
Key valuation signals for BKK:APCO-R:
Forward PE Ratio: 0.00
GF Value™: ฿7.61 vs. price of ฿6.27 (17.6% below fair value)
No single metric tells the full story. See the BKK:APCO-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Asian Phytoceuticals PCL engages in the manufacturing and marketing of herbal healthcare products. The company engages in the production and distribution of dietary supplements, cosmetics, and personal care products made from natural herbs. Its beauty products include skin nourishing and skin care products, hair loss treatment and hair growth products, slimming products, dietary supplements, and other nutritional products. Geographically, the company offers its services only in Thailand.
62GF Score
Get the complete analysis for BKK:APCO-R
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:APCO-R has been successfully added to your 